Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05586178 · ClinicalTrials.gov registry record · NA
Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 177,720
- Enrollment target
NCT05586178 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 177,720 participants.
The verdict
NCT05586178, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 177,720 participants
- Enrollment target
Study Summary
This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.
Interventions
- BEHAVIORAL Reminder that facilitates action
- BEHAVIORAL Consistency framing
- BEHAVIORAL Information provision about the uniqueness of the bivalent booster
- BEHAVIORAL Information provision about bivalent booster eligibility
- BEHAVIORAL Information provision about the severity of COVID-19 symptoms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177,720 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05586178
The ClinicalTrials.gov registry entry for NCT05586178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177,720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Reminder that facilitates action is the first listed.
NCT05586178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05586178 about?
NCT05586178 is a clinical study titled "Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake". This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booste...
What is the current status of trial NCT05586178?
This trial is currently completed. It is a NA study. The enrollment target is 177,720 participants. The study started on 2022-10-18. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05586178?
The interventions under investigation include: Reminder that facilitates action (BEHAVIORAL), Consistency framing (BEHAVIORAL), Information provision about the uniqueness of the bivalent booster (BEHAVIORAL), Information provision about bivalent booster eligibility (BEHAVIORAL), Information provision about the severity of COVID-19 symptoms (BEHAVIORAL).
Who is sponsoring clinical trial NCT05586178?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.